Attention deficits following ADEM ameliorated by guanfacine.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 20562462.
- Also identified by DOI 10.1136/jnnp.2009.195792 and PMC identifier 3090126.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors report here the case of a patient with severe deficits in arousal and sustained attention, associated with hemispatial neglect. These impairments were secondary to acute disseminated encephalomyelitis, with bilateral involvement of the medial nuclei and pulvinar of the thalamus. Treatment with the noradrenergic agonist guanfacine, previously used for attention deficits in attention deficit/hyperactivity disorder and stroke, was associated with a significant amelioration of both the spatial and sustained attention impairments in neglect. Guanfacine may prove to be a useful tool in the treatment of disorders of attention associated with neurological conditions.
Medical subject headings
- Adrenergic alpha-2 Receptor Agonists
- Attention
- Encephalomyelitis, Acute Disseminated
- Guanfacine
- Perceptual Disorders